Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

Emmanuel Tsochatzis

Chair of Scientific Committee

Prof. Emmanuel Tsochatzis (MD, MSc, FEBTM, FRCP, PhD) is a Professor of Hepatology and Consultant Hepatologist at the UCL Institute for Liver and Digestive Health in the Royal Free Hospital, London, UK, and Head of the Centre for Metabolic Liver Diseases. He leads the specialist multidisciplinary service in NAFLD at the Royal Free Hospital and has an active research programme in NAFLD. His clinical and research interests include NAFLD, non-invasive fibrosis assessment, cirrhosis, and portal hypertension. Prof. Tsochatzis finished his specialty training and his PhD at Hippokration General Hospital in Greece, before moving to the Royal Free Hospital to carry out post-doctoral research under the late Prof. Andy Burroughs.

He is the recipient of both the Rising Star in Gastroenterology prize by the UEG and the EASL Physician Scientist Fellowship. He was a member of the editorial board of Hepatology from 2017 to 2019. He is a member of the steering committee of the Baveno collaboration for portal hypertension. He has led several international research collaborations resulting in more than 220 publications in peer-reviewed journals. His work on the cost-effectiveness of non-invasive fibrosis tests has informed the WHO guidelines on diagnosis and treatment of both HBV and HCV. He has also designed and implemented a primary care pathway for NAFLD referrals to secondary care. He has received funding for his research from NIHR, EASL, and EU Horizon 2020.

Scroll to Top

Search EASL